Personalized Tobacco Treatment in Primary Care (MOTIVATE)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWashington University School of Medicine

About this trial

This study examines the application of precision treatment intervention for smoking cessation from both the clinician perspective and patient perspective, and compares it to usual care on tobacco treatment in the primary care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This approach may increase effectiveness and adherence for the patient, and increase the clinician's likelihood of prescribing.

Eligibility criteria

Qualifiers

Clinician from participating clinic

At least 18 years of age

Can speak and understand English

Patient at participating clinic

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Precision Treatment
  • Usual Care

Treatment groups

850 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Washington University School of Medicine

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

National Cancer Institute (NCI)

Collaborator